London Stock Exchange welcomes Graft Polymer Plc to the Main Market
The London Stock Exchange today welcomes Graft Polymer (UK) PLC, a business focused on the development of polymer modification, bio/food supplements and drug delivery systems, to the Main Market, trading under the ticker symbol “GPL”.
Graft Polymer is an early-stage company with a state-of-the-art polymer research and development, manufacturing, and operational facility based in Slovenia. The Company has successfully raised £5.0m as part of the IPO financing to fund the accelerated growth, expand the Group’s research and production facility in Slovenia to meet rising customer demand, upgrade existing facilities to enable future IP registration, and increase both inventory and marketing opportunities following expected increased sales.
The Company’s main niche is polymer modification, which is a key global challenge in the polymer industry, and the main instrument for creating modern composite materials. Graft Polymer has developed a unique suite of polymer modification technologies, which can improve existing products and processing methodologies by enhancing performance, simplifying manufacturing, reducing material consumption, widening the choice of feedstocks, and reducing costs.